MAPK3 and neoplasm: Intracellular levels of reactive oxygen species (ROS) were elevated by circulatory treatment, activating the extracellular signal-regulated kinases (ERK1/2); the ERK1/2 activation enhanced tumor cell migration and extravasation in a trans-endothelial assay as well as in a zebrafish model.